Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10930747 | Cytotherapy | 2005 | 12 Pages |
Abstract
We conclude that exogenous IL-2 is not required for anti-tumor activity of CD3/CD28-activated CD8+ cells early after adoptive transfer, but promotes T-cell persistence that confers disease protection at more remote times.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
D.P.M. MD, PhD, D. Baskar, F.A. Urban, M.S. Friedman, T.M. Braun, K.T. McDonagh,